(Q39379400)

11 September 2017

Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study (English)

1 reference

11 September 2017

0 references

0 references

Göran Lind

1

1 reference

11 September 2017

Björn A Meyerson

series ordinal

2

1 reference

11 September 2017

Jaleh Winter

series ordinal

3

1 reference

11 September 2017

Bengt Linderoth

series ordinal

4

1 reference

11 September 2017

1 August 2004

1 reference

11 September 2017

European Journal of Pain

1 reference

11 September 2017

8

1 reference

11 September 2017

4

1 reference

11 September 2017

377-383

1 reference

Effects of spinal cord stimulation on touch-evoked allodynia involve GABAergic mechanisms. An experimental study in the mononeuropathic rat.

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Spinal cord stimulation--a long-term evaluation in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Physiology of spinal cord stimulation: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Gamma-aminobutyric acid is released in the dorsal horn by electrical spinal cord stimulation: an in vivo microdialysis study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Intrathecal adenosine administration: a phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

A new approach to control central deafferentation pain: spinal intrathecal baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Efficacy of spinal cord stimulation: 10 years of experience in a pain centre in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Intrathecal baclofen: a useful agent in the treatment of well-established complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Pharmacokinetics of exogenous adenosine in man after infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Adenosine and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Modulation of spinal pain mechanisms by spinal cord stimulation and the potential role of adjuvant pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

Adenosine for pain control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2003.11.002

10.1016/J.EJPAIN.2003.11.002

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference